Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Funded by the company, the studies utilised data from the Swedish National Diabetes Register.
Medical Devices
Glucotrack hits trial success for direct blood measuring CGM
Tivic hits enrolment target for vagus nerve stimulation trial
Intelligent gears up for FDA approval of fingerprint drug detection device
Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
Nexalin trials Halo neurostimulation device in traumatic brain injury
Mixed results for Nexalin’s transcranial alternating current stimulation trial
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
